mGluR8

Metabotropic glutamate receptor 8 (mGluR8) functions primarily as a presynaptic autoreceptor, modulating glutamatergic and GABAergic neurotransmission^[1][2][3]. Mechanistically, mGluR8 activation reduces cytosolic Ca²⁺ influx in rod photoreceptors via a pertussis toxin-sensitive G protein, likely through the βγ subunit, thereby regulating neurotransmitter release^[1]. In the mammalian retina, mGluR8a localizes both pre- and postsynaptically across the outer and inner plexiform layers, contributing to synaptic processing in scotopic and photopic pathways^[4]. Compared with related group III isoforms such as mGluR4, mGluR8 exhibits distinct synaptic distribution and behavioral effects, influencing anxiety measures and sensorimotor performance in knockout models^[5][2]. In disease models, mGluR8 modulates neuropathic pain by restraining TNF-α and IL-1β expression in the red nucleus, indicating its potential for targeted analgesic interventions^[6]. Pharmacologically, mGluR8-specific agonists like (S)-3,4-DCPG and positive allosteric modulators such as AZ12216052 reduce anxiety-like behaviors and can differentially affect chemotherapeutic responses in human neuroblastoma cells depending on cell differentiation status^[7][3]. These modulators demonstrate isoform-specific activity and are valuable tools for dissecting mGluR8 functions in both neuronal development and disease-relevant experimental paradigms^[7][3].